esketamine group
KY-2024-332-02-02
Unknown small_molecule active
Quick answer
esketamine group for Postherpetic Neuralgia is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Postherpetic Neuralgia
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active